Transforming growth factor-beta (TGF-β) is a cytokine with three isoforms in humans and employs two serine/threonine kinase receptors to trigger messenger proteins (SMADs), thereby inducing the expression of genes essential to multiple roles in the onset and progression of GBM (Figure 7) [161,162]. This evidence concerns the gene TGFB1 and glioblastoma.